Engineering major, Siemens Limited, is expected to come out with its annual numbers soon. In this article we have looked at the 9 months results of the company for the last three years and tried to gauge the future performance of the company.
Operating Profit (EBDIT)
Operating Profit Margin (%)
Interest income (net)
Profit before Tax
Profit after Tax/(Loss)
Net profit margin (%)
No. of Shares (eoy) (m)
Diluted Earnings per share (Rs)*
*annualized, **9mFY04 upon 9mFY03
In 9MFY04 the companyís topline grew by around 8% but bottomline has improved significantly mainly due to increased extra ordinary income. Since revenues for engineering companies are contract based, last quarter contributes to a major chunk of revenues. So we can expect a higher growth in topline in the fourth quarter. For Siemens, historically fourth quarter has been contributing 30% to total revenues. Going by the same trend, the company is likely to show around 10% increase in the topline for FY04.
Letís have a look at the segmental break up of the revenues for the company.
Segment Revenue (Rs m)
Information & Communication
Automation & Drives
Industrial Solutions & Services
Healthcare & Other Services
Contribution of automation and drive segment has grown from 28% in 9MFY03 to 31% in 9MFY04. The PBIT margins from this segment are lower at around 5% as compared to its competitor ABB that operates at around 11% in the same segment. Automation is expected to remain a topline growth driver going ahead, as the order backlog from this segment is strong. Also, as Siemens gains experience in this business, its margins are likely to improve and come in line with its peers.
Contribution of power business has declined from 30% in 9MFY03 to 24% in 9MFY04 mainly due to cancellation of some power orders. However, the PBIT margin from this segment is higher, at around 15% for 9MFY04. In power, since company is into both generation and T&D equipment manufacturing, the growth in Indian power sector causes a lot of optimism.
Information communication business contributes around 5% to revenues of the company. Siemens is trying to increase the revenues from this segment in India through tie-ups with cellular service providers and is trying to capture the unexplored areas like Rajasthan. Contribution of healthcare business has remained stable at around 18% for the last two years. The medical equipment business is expected to pep up revenues as the parent company proposes to make India a manufacturing hub for medical equipment primarily for exports to Asian countries. Though this move could enhance the topline figure, poor margins remain a cause of concern. Unless margins improve, it is likely to be a drag on overall profitability.
At the current price level of 530, the stock trades at P/E multiple of 15.3x annualised 9MFY04 earnings and the market cap to sales ratio stands at 1.3x. Historically, the last quarter has contributed around 35% of the net profits. Extrapolating the same trend for FY04 estimates, Siemens is trading at a P/E of just of 13x FY04 estimated earnings.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India. Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407